A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells.
In this article we show that rabbit endometrial cells express leptin receptor and that human leptin triggers phosphorylation of signal transducer and activator of transcription 3 and up-regulates the expression of interleukin- 1 receptor type I as was previously found in human endometrial cells. Interestingly, leptin also upregulates the secretion of leukemia inhibitory factor and expression of its receptor by rabbit endometrial cells. Analysis of a structural model of the leptin-leptin receptor complex suggested that helices I and III of the human leptin structure were likely sites of interaction with the cytokine binding domain of leptin receptor. Accordingly, we synthesized a peptide (LPA-2) comprising helix III (residues 70-95) and investigated its ability to inhibit leptin receptor function. The effects of LPA-2 were assayed in rabbit endometrial cells, and an antileptin receptor antibody and a scrambled version of LPA-2 were used as positive and negative controls, respectively. LPA-2 binds specifically and with high affinity (Ki ~ 0.6 x 10-10 M) to leptin receptor and is a potent inhibitor of its functions in rabbit endometrial cells. Because leukemia inhibitory factor and interleukin- 1 have been implicated in embryo implantation, our results raise the possibility that the LPA-2-induced inhibition of leptin receptor may be exploited to study the actions of leptin in endometrium and in other tissues under conditions characterized by abnormal leptin production.
Gonzalez
Ruben Rene
RR
Boston Biomedical Research Institute (BBRI), Watertown, MA 02111, USA. gonzalezr@bbri.org
Leavis
Paul C
PC
D000818:Animals; D002478:Cells, Cultured; D004717:Endometrium / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism; D020738:Leptin / Q000378:metabolism* / Q000494:pharmacology; D053605:Leukemia Inhibitory Factor; D010446:Peptide Fragments / Q000378:metabolism* / Q000494:pharmacology; D011817:Rabbits; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D017472:Receptors, Interleukin-1 / Q000187:drug effects / Q000378:metabolism; D054411:Receptors, Leptin; D011994:Recombinant Proteins; D015854:Up-Regulation
D015850:Interleukin-6; C515448:LEPR protein, human; C507837:LIF protein, human; D020738:Leptin; D053605:Leukemia Inhibitory Factor; D010446:Peptide Fragments; D011956:Receptors, Cell Surface; D017472:Receptors, Interleukin-1; D054411:Receptors, Leptin; D011994:Recombinant Proteins